Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 484-490

  Bilsky, Edward J ^a   Bernstein, Robert N ^a   Wang, Zaijie ^b   Sadée, Wolfgang ^b   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; NALOXONE; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DESENSITIZATION; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOTHESIS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TAIL FLICK TEST;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; ENZYME INHIBITORS; ISOQUINOLINES; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; PEPTIDES; PIPERAZINES; PROTEIN KINASE C; RECEPTORS, OPIOID, MU; SOMATOSTATIN;

EID: 0030439407     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ARDEN, J. R., SEGREDO, V., WANG, Z., LAMEH, J. AND SADEE, W.: Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK-293 cells. J. Neurochem. 65: 1636-1645, 1995.
2. ALREJA, M. AND AGHAJANIAN, G. K.: Pacemaker activity of locus coeruleus neurons: Whole-cell recordings in brain slices shows dependence on cAMP and protein kinase A. Brain Res 556: 339-343, 1991.
3. BARKER, E. L., WESTPHAL, R. S., SCHMIDT, D. AND SANDERS-BUSH, E.: Constitutively active 5-hydroxytryptamine 2c receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269: 11687-11690, 1994.
4. 2 (CTOP) in mice. Eur. J. Pharmacol. 150: 355-360, 1988.
5. HIDAKA, H., INAGAKI, M., KAWAMOTO, S. AND SASAKI, Y.: Isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1984.
6. HYLDEN, J. L. AND WILCOX, G. W.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
7. IORIO, M. A. AND FRIGENI, V.: Narcotic agonist/antagonist properties of quaternary diastereoisomers derived from oxymorphone and naloxone. Eur. J. Med. Chem. 19: 301-303, 1984.
8. JONES, D. N. AND HOLTZMAN, S. G.: Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J. Pharmacol. Exp. Ther. 262: 638-645, 1992.
9. KRAMER, T. H., SHOOK, J. E., KAZMIERSKI, W., AYRES, E. A., WIRE, W. S., HRUBY, V. J. AND BURKS, T. F.: Novel peptidic mu opioid antagonists: Pharmacological characterization in vito and in vivo. J. Pharmacol. Exp. Ther. 249: 544-551, 1989.
10. LEFKOWITZ, R. J. G.: Protein coupled receptor kinases Cell 74: 409-412, 1993.
11. MALDONADO, R., NEGUS, S. AND KOOB, G. F.: Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31: 1231-1241, 1992.
12. NARITA, M., SENG, Y., MAKIMURA, M., HOSKINS, B. AND HO, I. K.: A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur. J. Pharmacol. 271: 543-545, 1994.
13. NESTLER, E. J.: Molecular mechanisms of drug addiction. J. Neurosci. 12: 2439-2450, 1992.
14. NIXON, J. S., WILKINSON, S. E., DAVIS, P. D., SEDGWICK, A. D., WADSWORTH, J. AND WESTMACOTT, D.: Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases. Agents Actions 32: 188-193, 1991.
15. PORRECA, F. AND BURKS, T. F.: The spinal cord as a site of opioid gastrointestinal effects in mice J. Pharmacol. Exp. Ther 227: 22-27, 1983.
16. PORRECA, F., MOSBERG, H. I., HURST, R., HRUBY, V. J. AND BURKS, T. F.: Roles of μ, δ and κ opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J. Pharmacol. Exp. Ther. 230: 341-348, 1984.
17. RAYA, A, GALLEOO, J., HERMENEGILDO, C., PUERTAS, F. J., ROMERO, F. J., FELIPO, V., MINANA, M. D., GRISOLIA, S. AND ROMA, J.: Prevention of the acute neurotoxic effects of phenytoin on rat peripheral nerve by H7, an inhibitor of protein kinase C. Toxicology 75: 249-256, 1992.
18. SADÉE, W., WANG, Z., ARDEN, J. R. AND SEGREDO, V.: Constitutive activation of the μ-opioid receptor: A novel paradigm of receptor regulation in narcotic analgesia, tolerance and dependence. Analgesia 1: 11-14, 1994.
19. SHOOK, J. E , PELTON, J. T., KAZMLERSKI, W., LEMCKE, P. K., VILLAR, R. G., HRUBY, V. J. AND BURKS, T. F.: A cyclic somatostatin analog that precipitates withdrawl in morphine-dependent mice. NIDA Res. Monogr. 76: 295-301, 1987.
20. WANG, Z., BILSKY, E. J., PORRECA, F. AND SADÉE, W. CONSTITUTIVE M.: opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54: PL339-350, 1994a.
21. WANG, Z., ARDEN, J. R., SEGREDO, V. AND SADEE, W.: Agonist induced constitutive activation of the μ opioid receptor by phosphorylation. Reg. Peptides 54: 323-324, 1994b.
22. WAY, E. L., LOH, H. H. AND SHEN, F-H.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167: 1-8, 1969.
23. YANO, I. AND TAKEMORI, A. E.: Inhibition by naloxone of tolerance and dependence in mice treated acutely or chronically with morphine. Res. Commun. Chem. Pathol. Pharmacol. 16: 721-733, 1977.
24. YU, V. C. AND SADEE, W.: Efficacy and tolerance of narcotic analgesics at the μ opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245: 350-355, 1988.